First-Line Drug for Unstable Bradycardia According to ACLS Guidelines
Atropine is the first-line drug for unstable bradycardia, dosed at 0.5 to 1 mg IV, repeated every 3 to 5 minutes as needed, up to a maximum total dose of 3 mg. 1, 2
Dosing Algorithm
Initial dose: Start with 0.5 to 1 mg IV push
- Repeat dosing: If bradycardia persists with ongoing signs of instability, give additional 0.5 to 1 mg doses every 3 to 5 minutes
- Maximum cumulative dose: 3 mg total (some guidelines cite 1.5 to 3 mg range) 1, 2
- Avoid doses <0.5 mg: These may paradoxically worsen bradycardia through a parasympathomimetic effect 3, 2
Recent evidence suggests that 1 mg initial doses may be more effective than 0.5 mg, with higher first-dose success rates (44.8% vs 25.3%), less need for additional atropine, and reduced need for rescue therapies 4. However, the established ACLS guidelines provide the 0.5 to 1 mg range as acceptable.
When to Use Atropine
Atropine is indicated for symptomatic bradycardia when the patient exhibits:
- Hypotension (systolic BP <90 mmHg)
- Altered mental status
- Ischemic chest pain
- Acute heart failure
- Other signs of shock or poor perfusion 2
The bradycardia must be causing these symptoms—asymptomatic or minimally symptomatic patients generally do not require immediate treatment unless the rhythm is likely to progress (e.g., Mobitz type II in acute MI) 2.
Critical Caveats and Pitfalls
Atropine will likely fail or should be avoided in:
Infranodal blocks (Mobitz type II, third-degree AV block with wide QRS): The block is below the AV node in the His-Purkinje system where vagal tone has minimal effect. Move directly to transcutaneous pacing or chronotropic infusions 3, 2
Post-cardiac transplant patients: The denervated heart lacks vagal innervation, making atropine ineffective and potentially harmful—it may paradoxically cause high-degree AV block 1, 2, 5, 6
Acute coronary ischemia/MI: Use cautiously—increasing heart rate may worsen ischemia or extend infarct size. Titrate to minimally effective heart rate (approximately 60 bpm) rather than aggressively normalizing 3, 2
Second-Line Options When Atropine Fails
If atropine is ineffective after full dosing (3 mg total):
Chronotropic infusions:
- Epinephrine: 2 to 10 mcg/min IV infusion 1, 2
- Dopamine: 5 to 20 mcg/kg/min IV infusion (start at 5 mcg/kg/min, increase by 5 mcg/kg/min every 2 minutes; doses >20 mcg/kg/min risk vasoconstriction and arrhythmias) 1, 2, 5, 6
Transcutaneous pacing: Should be considered when atropine fails, though evidence suggests it may not be more effective than second-line drug therapy 1, 2. It serves as a bridge to transvenous pacing in refractory cases.
Evidence Quality
The ACLS recommendations are based on one randomized trial and multiple observational studies showing atropine improves heart rate and symptoms in both in-hospital and out-of-hospital symptomatic bradycardia 1. The evidence is consistent across the 2010 International Consensus guidelines and 2010 AHA ACLS guidelines, with the 2019 ACC/AHA/HRS guidelines providing similar recommendations (Class IIa, Level of Evidence C-LD) 5, 6.
Approximately 50% of patients with hemodynamically unstable bradycardia respond to atropine (either partially or completely), with adverse responses being uncommon 7. Most patients who respond do so during the prehospital interval, and those requiring higher total doses or multiple doses are more likely to have AV block rather than sinus bradycardia 7.